Quantcast

Latest Glomerulonephritis Stories

2015-03-27 08:26:09

Real-world retrospective cases evaluate proteinuria response to treatment in patients with various kidney disorders resulting in nephrotic syndrome DALLAS, March 27, 2015 /PRNewswire/ --

2015-03-20 08:27:40

DALLAS, March 20, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Glomerulonephritis - Pipeline Review, H1 2015" report to its store.

2015-01-21 04:20:56

STOCKHOLM, January 21, 2015 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces that its IND for Nefecon(R) is now

2014-12-15 08:30:06

- Anthera to receive up to $48,000,000 plus future product margin on commercial supply HAYWARD, Calif., Dec. 15, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc.

2014-11-03 04:21:41

STOCKHOLM, November 3, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces that clinical results from the initial

2014-10-27 04:22:05

STOCKHOLM, October 27, 2014 /PRNewswire/ -- Key patent granted in Japan Pharmalink AB, a specialty pharma company focused on

2014-08-11 20:23:57

LONDON, Aug.

2014-07-28 20:24:33

HAYWARD, Calif., July 28, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc.

2014-07-10 04:21:24

STOCKHOLM, July 10, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, has had core patents for its late-stage clinical

2014-05-13 08:33:02

HAYWARD, Calif., May 13, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc.


Word of the Day
bowerly
  • Large; stout; burly.
The word 'bowerly' is an alteration of 'burly'.